Media center

Press release
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients

November 19, 2024
Press release
Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients

November 19, 2024
Press release
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
Press release
Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin
March 25, 2024
Press release
Owkin expands collaboration with Sanofi to apply AI for drug positioning in immunology
March 21, 2024
Press release
Aster Insights and Owkin collaborate to accelerate research in breast cancer
April 12, 2024
Press release
Jean-Jacques Bienaimé appointed Chairman of the Board at Owkin
March 25, 2024
Access our Press Kit

Explore

Newest / Oldest
Select
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Owkin and ADC Therapeutics to build AI models to improve hematologic cancer treatment
April 27, 2022
Button
Owkin and ADC Therapeutics to build AI models to improve hematologic cancer treatment
April 27, 2022
Button
Press release
Owkin appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer
April 10, 2022
Button
Owkin appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer
April 10, 2022
Button
Press release
Owkin announces new Scientific Advisory Board chaired by world-leading precision oncologist
March 25, 2022
Button
Owkin announces new Scientific Advisory Board chaired by world-leading precision oncologist
March 25, 2022
Button
Press release
Fierce Medtech names Owkin a 'Fierce 15' Med Tech Company of 2021
March 7, 2022
Button
Fierce Medtech names Owkin a 'Fierce 15' Med Tech Company of 2021
March 7, 2022
Button
In the media
On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer
February 16, 2022
Button
On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer
February 16, 2022
Button
In the media
How AI is helping to treat HER2-low breast cancer patients
January 20, 2022
Button
How AI is helping to treat HER2-low breast cancer patients
January 20, 2022
The Times
Button
Press release
NHS trust and Owkin to develop AI tool to combat HER2 breast cancer
January 19, 2022
Button
NHS trust and Owkin to develop AI tool to combat HER2 breast cancer
January 19, 2022
Button
In the media
Owkin collaborates with UK hospitals to turbocharge AI breast cancer diagnosis
January 19, 2022
Button
Owkin collaborates with UK hospitals to turbocharge AI breast cancer diagnosis
January 19, 2022
Button
Press release
Owkin Co-founder argues a refocusing AI in medical research at 40th J.P. Morgan Healthcare Conference
January 16, 2022
Button
Owkin Co-founder argues a refocusing AI in medical research at 40th J.P. Morgan Healthcare Conference
January 16, 2022
Button
Press release
CONDOR, an Owkin precision medicine project, is awarded a €10m RHU grant
December 16, 2021
Button
CONDOR, an Owkin precision medicine project, is awarded a €10m RHU grant
December 16, 2021
Button
Press release
Owkin and Amgen use AI to improve cardiovascular risk prediction
December 16, 2021
Button
Owkin and Amgen use AI to improve cardiovascular risk prediction
December 16, 2021
Button
In the media
Sanofi signs a $270M strategic partnership with Owkin to research new treatments across four cancers
November 18, 2021
Button
Sanofi signs a $270M strategic partnership with Owkin to research new treatments across four cancers
November 18, 2021
Conor Hale
Button